Duchenne Muscular Dystrophy Therapeutics Report

By www.reportprimer.com

Report Details

Report Name

Global Duchenne Muscular Dystrophy Therapeutics Market Size, Status And Forecast 2024-2031 Story

Pages

108

Price

$ 3900

Features

Duchenne Muscular Dystrophy Therapeutics Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              Bristol-Myers Squibb
FibroGen (US)
Italfarmaco (Italy)
Marathon
NS Pharma (US)
PTC Therapeutics (US)
Pfizer
ReveraGen BioPharma (US)
Santhera Pharmaceuticals (Switzerland)
Sarepta Therapeutics (US)